iPierian

About:

iPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s.

Website: http://ipierian.com/

Twitter/X: iPierian

Top Investors: Mission BioCapital, Biogen, Google Ventures, Mitsubishi UFJ Capital, Kleiner Perkins

Description:

We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson's, and other major unmet medical needs.

Total Funding Amount:

$80.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)ipierian.com

Founders:

Deepak Srivastava, George Daley

Number of Employees:

1-10

Last Funding Date:

2017-01-01

IPO Status:

Private

Industries: